Active substanceLevomenthol solution in menthil isovalerateLevomenthol solution in menthil isovalerate
Similar drugsTo uncover
  • Validol
    capsules n / az. 
    MARBIOFARM, OJSC     Russia
  • Validol
    pills n / az. 
    UPDATE OF PFC, CJSC     Russia
  • Validol
    pills n / az. 
    MARBIOFARM, OJSC     Russia
  • Validol
    pills n / az. 
    DALHIMFARM, OJSC     Russia
  • Validol
    pills n / az. 
  • Validol
    capsules n / az. 
    MINSKINTERKAPS, UP     Republic of Belarus
  • Validol
    capsules n / az. 
    LYUMI, LLC     Russia
  • Validol
    pills n / az. 
  • Validol
    pills n / az. 
    EVROFARM, CJSC     Russia
  • Validol
    pills n / az. 
    ATOLL, LLC     Russia
  • Validol
    capsules n / az. 
    MELIGEN FP, CJSC     Russia
  • Validol
    pills n / az. 
  • Validol with glucose
    pills n / az. 
    MEDISORB, CJSC     Russia
  • VALIDOLE WITH ISOMALT
    pills n / az. 
    AVEKSIMA, JSC     Russia
  • Kormenthal
    capsules n / az. 
    GIDIMAS, CJSC     Lithuania
  • Dosage form: & nbspsublingual tablets
    Composition:

    Composition per one tablet:

    active substance:

    levomenthol solution in menthyl isovalerate (validol) 0.060 g

    Excipients:

    sucrose (sugar) -1,157 g

    calcium stearate - 0.006 g.

    Description:Round flat cylindrical tablets with a facet and a risk, white or white with a yellowish shade of color with a characteristic smell of menthol.Grayish blotches are allowed.
    Pharmacotherapeutic group:Coronarodilating agent of reflex action
    ATX: & nbsp

    C.01.E.X   Other combination drugs for the treatment of heart disease

    Pharmacodynamics:

    Has a sedative effect, possesses moderate reflex vasodilator action, caused by irritation of sensitive nerve endings. It stimulates the production and release of enkephalins, endorphins and a number of other peptides, kinins (due to stimulation of mucosal receptors), which actively participate at regulation of vascular permeability, the formation of pain.

    Pharmacokinetics:When taken under the tongue, the therapeutic effect occurs, on average, after 5 minutes, while up to 70% of the drug is released within 3 minutes.
    Indications:Functional cardialgia, a syndrome of "motion sickness" (nausea, vomiting in sea and air sickness).
    Contraindications:

    Hypersensitivity to the components of the drug. Deficiency of sucrose / isomaltose, intolerance to fructose, glucose-galactose malabsorption (because the preparation contains sucrose).

    Carefully:

    It should be prescribed with caution to a patient with diabetes mellitus (the drug contains sucrose). 1 tablet contains bread units - 0.096-0.116 XE (0.106 XE).

    Pregnancy and lactation:During pregnancy and lactation, Validol is prescribed only if the expected therapeutic effect for the mother exceeds the possible negative effect of the drug on the fetus and the infant.
    Dosing and Administration:

    Validol is prescribed under the tongue. The tablet should be kept in the mouth under the tongue until it is completely resorbed. Take 1 tablet 2-3 times a day. The daily frequency and duration of Validol intake is determined depending on the effectiveness of treatment. If the effect is not sufficiently pronounced, or when in individual patients the next 5 minutes after taking the drug effect is not observed, you need to contact your doctor for another therapy.

    Side effects:

    With prolonged intake of Validol, mild nausea, lacrimation, dizziness may occur. These phenomena usually pass by themselves.

    Overdose:

    Headache, nausea, nervous state, lowering blood pressure, suppressing the central nervous system.In case of an overdose, it is necessary to cancel the drug and prescribe symptomatic therapy.

    Interaction:

    When combined with other drugs that depress the central nervous system, strengthens the effect of the latter. Simultaneous use of the drug with nitrates reduces the headache that occurs when they are used.

    Effect on the ability to drive transp. cf. and fur:

    In connection with the possibility of side effects with prolonged use of the drug, the ability to drive a vehicle or mechanisms can be reduced.

    Form release / dosage:

    Tablets are sublingual, 60 mg.

    Packaging:

    For 8 tablets in a contour mesh box made of polyvinylchloride film and aluminum foil.

    1, 2 contour packs of 8 tablets with instructions for use are placed in a pack of cardboard.

    Storage conditions:

    At a temperature of no higher than 25 ° C.

    Keep out of the reach of children.

    Shelf life:

    2 years.

    Do not use after the expiration date stated on the package.

    Terms of leave from pharmacies:Without recipe
    Registration number:LS-001117
    Date of registration:24.06.2011 / 29.06.2015
    Expiration Date:Unlimited
    The owner of the registration certificate:UPDATE OF PFC, CJSC UPDATE OF PFC, CJSC Russia
    Manufacturer: & nbsp
    Information update date: & nbsp18.01.2017
    Illustrated instructions
      Instructions
      Up